| Epidemiology | Lifetime | 815 | US 417 | 98.91 |
| Clinical Neurology | Lifetime | 438 | US 195 | 98.16 |
| Cognitive Neuroscience | Lifetime | 984 | US 502 | 97.27 |
| Otolaryngology | Lifetime | 252 | US 134 | 96.25 |
| Neuroscience of Neurology | Lifetime | 828 | US 329 | 91.93 |
| Sensory Systems | Lifetime | 476 | US 242 | 88.41 |
| Cognitive Neuroscience | 2021-2025 | 75 | US 30 | 98.92 |
| Epidemiology | 2021-2025 | 228 | US 76 | 98.32 |
| Clinical Neurology | 2021-2025 | 139 | US 48 | 96.65 |
| Sensory Systems | 2021-2025 | 68 | US 22 | 88.55 |
| Otolaryngology | 2021-2025 | 146 | US 55 | 87.62 |
| Anatomy | 2021-2025 | 25 | US 4 | 73.55 |
| Facial Nerve Paralysis Treatment and Research | Lifetime | 16 | US 11 | 99.43 |
| Ear Surgery and Otitis Media | Lifetime | 37 | US 25 | 99.21 |
| Meningioma and schwannoma management | Lifetime | 93 | US 60 | 99.32 |
| Neurofibromatosis and Schwannoma Cases | Lifetime | 75 | US 53 | 98.89 |
| Hearing Loss and Rehabilitation | Lifetime | 122 | US 53 | 98.94 |
| Ear and Head Tumors | Lifetime | 96 | US 63 | 98.76 |
| Hearing, Cochlea, Tinnitus, Genetics | Lifetime | 144 | US 81 | 98.70 |
| Noise Effects and Management | Lifetime | 203 | US 84 | 98.22 |
| Vascular Malformations Diagnosis and Treatment | Lifetime | 260 | US 162 | 98.11 |
| Vestibular and auditory disorders | Lifetime | 320 | US 139 | 97.50 |
| Head and Neck Surgical Oncology | Lifetime | 551 | US 309 | 97.62 |
| Cerebral Venous Sinus Thrombosis | Lifetime | 433 | US 215 | 95.42 |
| Bone Tumor Diagnosis and Treatments | Lifetime | 787 | US 356 | 95.49 |
| Salivary Gland Tumors Diagnosis and Treatment | Lifetime | 857 | US 363 | 95.30 |
| Teratomas and Epidermoid Cysts | Lifetime | 141 | US 86 | 93.91 |
| Adrenal and Paraganglionic Tumors | Lifetime | 945 | US 282 | 93.01 |
| Diversity and Career in Medicine | Lifetime | 872 | US 650 | 91.04 |
| Trigeminal Neuralgia and Treatments | Lifetime | 906 | US 304 | 87.20 |
| Hospital Admissions and Outcomes | Lifetime | 674 | US 462 | 84.04 |
| Soft tissue tumors and treatment | Lifetime | 512 | US 211 | 76.67 |
| Meningioma and schwannoma management | 2021-2025 | 5 | US 2 | 99.54 |
| Hearing, Cochlea, Tinnitus, Genetics | 2021-2025 | 5 | US 2 | 99.39 |
| Hearing Loss and Rehabilitation | 2021-2025 | 7 | US 4 | 99.53 |
| Neurofibromatosis and Schwannoma Cases | 2021-2025 | 4 | US 3 | 99.35 |
| Facial Nerve Paralysis Treatment and Research | 2021-2025 | 4 | US 1 | 99.19 |
| Ear Surgery and Otitis Media | 2021-2025 | 12 | US 1 | 98.01 |
| Noise Effects and Management | 2021-2025 | 36 | US 6 | 98.64 |
| Vascular Malformations Diagnosis and Treatment | 2021-2025 | 30 | US 21 | 98.05 |
| Vestibular and auditory disorders | 2021-2025 | 163 | US 25 | 93.01 |
| Ear and Head Tumors | 2021-2025 | 261 | US 77 | 83.32 |
| Cerebral Venous Sinus Thrombosis | 2021-2025 | 763 | US 248 | 70.61 |
| Teratomas and Epidermoid Cysts | 2021-2025 | 107 | US 52 | 65.16 |
